SCHEMBL25680766

SCHEMBL25680766

c1ccc(-c2ccc3cc(-c4nc(-c5ccccc5)nc(-c5cccc(-c6ccc(-c7cccc8ccccc78)c7ccccc67)c5)n4)ccc3c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
MAPT P10636 3/20 0.46
KDM4E B2RXH2 2/20 0.46
TP53 P04637 2/20 0.46
HSD17B10 Q99714 2/20 0.46
HPGD P15428 1/20 0.46
TSHR P16473 1/20 0.46
NFKB1 P19838 1/20 0.46
MAPK1 P28482 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
ATM Q13315 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
CA12 O43570 4/20 0.45
CA1 P00915 4/20 0.45
CA2 P00918 4/20 0.45
CA9 Q16790 4/20 0.45
MCL1 Q07820 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25680771 0.99 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2MAPTKDM4ETP53
SCHEMBL25680746 0.97 CA12 (0.48) ALDH1A1SMN1; SMN2MAPTKDM4ETP53
SCHEMBL25798727 0.97 CA12 (0.48) ALDH1A1SMN1; SMN2MAPTKDM4ETP53
SCHEMBL26278885 0.97 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2MAPTKDM4ETP53
SCHEMBL25680719 0.97 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2MAPTKDM4ETP53
SCHEMBL24770267 0.97 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2MAPTKDM4ETP53
SCHEMBL25471687 0.97 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2MAPTKDM4ETP53
SCHEMBL27252447 0.97 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2MAPTKDM4ETP53
SCHEMBL27257038 0.97 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2MAPTKDM4ETP53
SCHEMBL26278535 0.97 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2MAPTKDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11690292-B2 Organic electronic element comprising a compound for organic electronic element and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-06-27 US disclosed
US-11690292-B2 Organic electronic element comprising a compound for organic electronic element and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-06-27 US disclosed
US-20230129535-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING A COMPOUND FOR ORGANIC ELECTRONIC ELEMENT AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-04-27 US disclosed
US-20230129535-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING A COMPOUND FOR ORGANIC ELECTRONIC ELEMENT AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11690292-B2 Organic electronic element comprising a compound for organic electronic element and an electronic device thereof ESR1, EML4, ORAI2 ALDH1A1 601/4885SMN1; SMN2 2010/4885MAPT 1268/4885
US-20230129535-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING A COMPOUND FOR ORGANIC ELECTRONIC ELEMENT AND AN ELECTRONIC DEVICE THEREOF ESR1, EML4, ORAI2 ALDH1A1 601/4885SMN1; SMN2 2010/4885MAPT 1268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.